In a June 2022 Panel, an FDA official stated, “the adjusted rate ratios are all elevated, some of them significantly elevated” for Myocarditis as a result of the mRNA vaccines. “There can be long-term, residual effects of myocarditis.”
FDA: “Significantly Elevated Risks” and “Long-Term Effects” from Vaccinations
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.